COVID-19 research in critical care: the good, the bad, and the ugly.
作者信息
Salluh Jorge I F, Arabi Yaseen M, Binnie Alexandra
机构信息
Department of Critical Care and Postgraduate Program in Translational Medicine, D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
Programa de Pós-Graduação em Clínica Médica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
出版信息
Intensive Care Med. 2021 Apr;47(4):470-472. doi: 10.1007/s00134-021-06367-5. Epub 2021 Mar 1.
Abstract
摘要
相似文献
1
COVID-19 research in critical care: the good, the bad, and the ugly.
Intensive Care Med. 2021 Apr;47(4):470-472. doi: 10.1007/s00134-021-06367-5. Epub 2021 Mar 1.
2
Translating stem cells to the clinic: the good, the bad, and the ugly.
Ann Neurol. 2008 Mar;63(3):A17-21. doi: 10.1002/ana.21253.
3
[Clinical research in COVID-19 era].
Rev Med Chil. 2020 May;148(5):707-708. doi: 10.4067/S0034-98872020000500707.
4
Impact of clinical and patient pathway changes on paediatric research during the national COVID-19 response.
Arch Dis Child. 2021 Dec;106(12):e50. doi: 10.1136/archdischild-2021-322865. Epub 2021 Aug 24.
5
Impact of COVID-19 on health services, vascular surgery and medical research.
Int Angiol. 2021 Jun;40(3):177-179. doi: 10.23736/S0392-9590.21.04623-X. Epub 2021 Feb 12.
6
Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward.
Gastroenterology. 2021 Dec;161(6):1758-1763. doi: 10.1053/j.gastro.2021.06.080. Epub 2021 Aug 10.
7
The ugly, the bad and the good: Reflections on a COVID-19-devastated year.
Waste Manag Res. 2021 Jun;39(1_suppl):1-2. doi: 10.1177/0734242X211024386. Epub 2021 Jun 2.
8
COVID-19 Pandemic: A Wake-Up Call for Indian Medical Research.
Neurol India. 2021 Mar-Apr;69(2):513-514. doi: 10.4103/0028-3886.314586.
9
Non-Covid-19 clinical research in the era of pandemic.
Am J Emerg Med. 2021 Jan;39:231-232. doi: 10.1016/j.ajem.2020.05.013. Epub 2020 May 8.
10
Covid-19 and the Investigator Pipeline.
N Engl J Med. 2021 Jul 1;385(1):7-9. doi: 10.1056/NEJMp2100086. Epub 2021 Mar 24.
引用本文的文献
1
Efficacy of COVID-19 Treatments in Intensive Care Unit: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Crit Care Res Pract. 2024 Nov 27;2024:2973795. doi: 10.1155/ccrp/2973795. eCollection 2024.
2
COVID-19 Pandemic and Impact on Research Publications in Critical Care.
Crit Care Explor. 2024 Jun 5;6(6):e1103. doi: 10.1097/CCE.0000000000001103. eCollection 2024 Jun.
3
Structural under-reporting of informed consent, data handling and sharing, ethical approval, and application of Open Science principles as proxies for study quality conduct in COVID-19 research: a systematic scoping review.
BMJ Glob Health. 2023 May;8(5). doi: 10.1136/bmjgh-2023-012007.
4
The positive impact of COVID-19 on critical care: from unprecedented challenges to transformative changes, from the perspective of young intensivists.
Ann Intensive Care. 2023 Apr 11;13(1):28. doi: 10.1186/s13613-023-01118-9.
5
From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?
Biomedicines. 2022 Oct 18;10(10):2620. doi: 10.3390/biomedicines10102620.
6
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study.
Intensive Care Med. 2022 Jun;48(6):690-705. doi: 10.1007/s00134-022-06705-1. Epub 2022 May 21.
7
The association between therapeutic plasma exchange and the risk of mortality among patients critically ill with COVID-19: a meta-analysis.
F1000Res. 2021 Dec 14;10:1280. doi: 10.12688/f1000research.74972.1. eCollection 2021.
8
Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19.
J Clin Med. 2021 Dec 12;10(24):5815. doi: 10.3390/jcm10245815.
9
The gut in COVID-19.
Intensive Care Med. 2021 Sep;47(9):1024-1027. doi: 10.1007/s00134-021-06461-8. Epub 2021 Jul 8.
10
And once the storm is over… ICM will remain the intensivist's beacon.
Intensive Care Med. 2021 Jun;47(6):687-691. doi: 10.1007/s00134-021-06402-5. Epub 2021 Apr 28.
本文引用的文献
1
The WHO's chief scientist on a year of loss and learning.
Nature. 2020 Dec;588(7839):583-585. doi: 10.1038/d41586-020-03556-y.
2
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
3
Intensive care for COVID-19 in low- and middle-income countries: research opportunities and challenges.
Intensive Care Med. 2021 Feb;47(2):226-229. doi: 10.1007/s00134-020-06285-y. Epub 2020 Nov 13.
4
COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland.
Intensive Care Med. 2020 Nov;46(11):2035-2047. doi: 10.1007/s00134-020-06267-0. Epub 2020 Oct 9.
5
Organizational aspects of care associated with mortality in critically ill COVID-19 patients.
Intensive Care Med. 2021 Jan;47(1):119-121. doi: 10.1007/s00134-020-06249-2. Epub 2020 Oct 6.
6
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
JAMA. 2020 Oct 6;324(13):1307-1316. doi: 10.1001/jama.2020.17021.
7
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
8
Uncontrolled interventions during pandemics: a missed learning opportunity?
Intensive Care Med. 2020 Oct;46(10):1930-1931. doi: 10.1007/s00134-020-06180-6. Epub 2020 Jul 23.
9
Critical care journals during the COVID-19 pandemic: challenges and responsibilities.
Intensive Care Med. 2020 Aug;46(8):1521-1523. doi: 10.1007/s00134-020-06155-7. Epub 2020 Jul 6.
10
Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies.
Anaesthesia. 2020 Oct;75(10):1340-1349. doi: 10.1111/anae.15201. Epub 2020 Jul 15.
Zotero 插件